Your Article Summary
Soluble Epoxide Hydrolase Gene Deletion Attenuates Renal Injury and Inflammation with DOCA-salt Hypertension
American Journal of Physiology: Renal Physiology, 06/25/09
Manhiani M et al. - The data demonstrate that Ephx2 gene deletion decreases blood pressure, attenuates renal inflammation, and ameliorates glomerular injury in DOCA-salt hypertension.
Related Articles
Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: Results from a phase II randomized, factorial, double-blind study of cediranib in patients with advanced solid tumors
Journal of Clinical Oncology, 11/13/09
Relevance Score: 94%
Practical strategies for management of hypertension in the elderly
Internet Source, 10/13/09
Relevance Score: 92%
Hypertension in Women: More Evidence for the Role of Lifestyle
Nursing for Women's Health, 10/12/09
Relevance Score: 92%
Hypertension treatment and management concerns in the elderly
Aging Health, 10/07/09
Relevance Score: 92%
Intradialytic Hypertension: A Less-Recognized Cardiovascular Complication of Hemodialysis
American Journal of Kidney Diseases, 10/28/09
Relevance Score: 91%
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-Term Stability of Cardiovascular and Catecholamine Responses to Stress Tests. An 18-Year Follow-Up Study
Hypertension, 12/07/09
Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Convertng Enzyme 2. Prevention of Angiotensin II–Dependent Hypertension
Hypertension, 12/07/09
Non-congenital heart disease associated pediatric pulmonary arterial hypertension
Progress in Pediatric Cardiology, 12/07/09

See Latest Articles